Association of CCR5 delta32 deletion with early death in multiple sclerosis.
about
Involvement of beta-chemokines in the development of inflammatory demyelinationCould FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequenciesA novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.Role and therapeutic value of dendritic cells in central nervous system autoimmunity.mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.Multiple sclerosis genetics: leaving no stone unturned.Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?Is the CCR5 Δ 32 mutation associated with immune system-related diseases?Dendritic cells as therapeutic targets in neuroinflammation.RANTES: a genetic risk marker for multiple sclerosis.CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population.The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients.
P2860
Q24801279-DDB70BE9-24B2-4B6A-BFAC-206BF6ADAD36Q27487233-7C071A7B-BCC2-4D4F-9716-DF86DB12B8A6Q34389532-EDD88388-274B-448B-B2FB-5C12982A504EQ34924088-93B4C041-C3EA-4B0F-BC18-A458A476D372Q35770689-9D22AEF2-5102-4B36-8669-C55A1565FBA6Q35825040-725631A3-0FEA-40C6-82FA-450AE1D47E6AQ36171871-C36A2CA7-184E-4ABD-9119-E963C8A4C493Q36963161-78E7B8A1-1298-4D9C-87DB-4FD72F4EE4C0Q38068379-835475BE-D2F0-412F-A281-579D5EF96828Q38771884-FADF0239-C521-4E21-BA77-D7DB9AFFD6A6Q39015228-E4F795BB-4492-4E06-9A2A-6351887180C9Q50920198-96C073BD-560D-4FC2-9731-1EA5927FE3F1Q50998405-55DD4187-F5FF-442F-BE2E-0D8D5555CE04Q51016561-D348C42E-6EB9-45A2-A92D-500E7D46981DQ54597660-4305D67A-A89B-4F21-918D-27B5AFC0B691
P2860
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@en
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@nl
type
label
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@en
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@nl
prefLabel
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@en
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@nl
P2093
P2860
P1433
P1476
Association of CCR5 delta32 deletion with early death in multiple sclerosis.
@en
P2093
David E Comings
James MacMurray
Lawrence A Cone
Li S-C Cheng
Masoud Rostamkhani
Radhika Gade-Andavolu
Wallace W Tourtellotte
P2860
P304
P356
10.1097/01.GIM.0000127274.45301.54
P407
P577
2004-05-01T00:00:00Z
P5875
P6179
1037441995